跳至主要内容
临床试验/NCT03999528
NCT03999528已完成不适用

14-3-3η Protein, Disease Activity and Bone Mineral Density, in Female Patients With Rheumatoid Arthritis

Al-Azhar University1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2019年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
45
试验地点
1
主要终点
14-3-3η Protein and RA disease activity

研究概览

简要总结

Is to investigate the relation between 14-3-3η protein, disease activity, and bone mineral density in female patients with rheumatoid arthritis.

详细描述

Methods: all patients in the study will subject to:

  • Clinical assessment, WT, Height ,BMI, parity, medications,
  • DAS 28.
  • Serum 14-3-3η protein.
  • DEXA scan.

Grouping:

  • Group I: RA Patients with low BMD.
  • Group II: RA Patients with normal BMD.
  • Group III: normal control.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Rheumatoid arthritis according to ACR 2010 criteria with at least one year duration.
  • Premenopausal females.
  • On conventional DMARD with maximum 5 mg steroids.

排除标准

  • Biological treatment.
  • Previous antiresorptive treatment, or bone anabolics.
  • High dose corticosteroid.
  • Chronic renal or kidney disease.
  • Medications affecting bone metabolism.
  • Thyroid or adrenal dysfunction,

结局指标

主要结局

14-3-3η Protein and RA disease activity

时间窗: three months

percent of active RA disease and study the correlation between 14-3-3η Protein and RA disease activity

次要结局

  • 14-3-3η Protein and osteoporosis in RA patients(three months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Abogamal

Professor

Al-Azhar University

研究点 (1)

Loading locations...

相似试验